Sir Peter Mansfield Imaging Centre, University of Nottingham
Collaborating with the University of Nottingham and University College London, UCL, we were successfully funded to lead a Commercial Feasibility Study for a new generation magnetoencephalography - MEG - brain imaging system. Experts at the Sir Peter Mansfield Imaging Centre in Nottingham, a world-leading team, are pushing the boundaries of MEG to exciting new levels. UDA were tasked with analysing the feasibility of a commercial future and asked to produce a set of recommendations.
The outcomes included a comprehensive 10-year Roadmap which will now inform a follow-on project.
MEG is a non-invasive brain scanning system which detects magnetic fields produced from electrical activity generated by neurons in the brain.
Specifically important for paediatric work for children with epilepsy, and poised to become a significant tool for the further understanding of mental health disorders and neurodegenerative diseases
UDA regularly perform device and imaging equipment testing and evaluation services. Both well-known and emerging innovative companies require independent assessments relating to device performance, not only against industry benchmarks but also relating to competitive devices, and to gauge system performance limitations. Often this requires testing in a number of specific circumstances. UDA were tasked with designing and developing a complex test system for a range of highly sophisticated photon-counting detectors.
Throughout the project we worked closely with the client to produce a set of requirements. We then designed, developed, tested and documented a new test system to validate the detectors' sensitivity at extremely low levels.
UDA have been engaged on a long-term project with a multi-award-winning Medical Device development company. Developing innovative imaging based on alpha and beta detection the company engaged UDA to work as part of their development team, contributing physics and engineering expertise. This is a multi-year highly-innovative project where UDA are playing a lead role in the design and development of the overall system.
The outcome will be an IP-protected UK-designed medical device for a global market.
UDA are a collaborating partner in a 3-year project lead by the Fraunhofer Institute, IZM, in Germany. This collaboration brings together partners from four European countries and supports our strategy to develop European and International partnerships. The project is based on research into a new medical device. UDA are contributing regulatory and compliance know-how as well as technical and systems engineering capabilities.
Throughout the project UDA will work with all partners to ensure the system design coherence, interface coherence and to manage regulatory considerations.
UDA are working closely with several groups within the Quantum Technologies Hub. Focused on imaging and sensing we have projects with the University of Bristol and the University of Nottingham. An example of UDA's engagement in the Quantum programme is our work with the University of Bristol on squeezed light and paired sources.
Through this project UDA will work on very early stage technologies to help guide research towards the most likely commercial applications, thus impacting the potential to exploit future commercial opportunities.